Novartis 2019 guidance raises, helped by Sandoz generics unit

0
4

PHOTO FILE: Switzerland Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS / Arnd Wiegmann / File Photo

ZURICH (Reuters) – Novartis (NOVN.S) lifted full-year on oz ozoz ozoz oz oz oz oz oz

Forecast by 10 analysts in Refinitiv hole. T

The Basel-based company now expects 201% core t Sales expectations were also available.

Novartis highlights performance at Sandoz, where it says international business offset price declines in the United States.

It 's revised Sandoz 2019 sales forecasts upwards – last year. T

“Chief Executive Vas Narasimhan in a statement.

Reporting by John Miller; Neghaiwi. T

Our Standards:The Thomson Reuters Trust Principles.

(tagsToTranslate) US (t) NOVARTIS (t) RESULTS (T) Medical Equipment: (TRBC) (t) Performance / Results (t) Switzerland (t) Company News (t) t) Western Europe (t) Pharmaceuticals (TRBC) (t) Dividends (t) Europe (t) Pharmaceuticals and Medical Research (TRBC) (t) Healthcare (TRBC)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.